Compounds > 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Epilepsy

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Epilepsy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Costa, DC; Ell, PJ; Moriarty, J; Ring, HA; Trimble, MR; Verhoeff, NP1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Epilepsy

ArticleYear
Striatal dopamine receptor binding in epileptic psychoses.
    Biological psychiatry, 1994, Mar-15, Volume: 35, Issue:6

    Topics: Adult; Basal Ganglia; Benzamides; Binding Sites; Epilepsy; Humans; Male; Middle Aged; Occipital Lobe; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

1994